Is Baiyunshan Banlangen effective against the new coronavirus?Zhong Nanshan pointed out that someone took it out of context

A few days ago, a news and a video of “Academician Zhong Nanshan’s team found that compound Banlangen is effective against the new coronavirus through in vitro research” went viral on the Internet, causing consumers in various markets to snap up Banlangen, and the stock price of Baiyunshan (600332.SH) soared.

On October 23, Academician Zhong Nanshan, a recipient of the Medal of the Republic and an academician of the Chinese Academy of Engineering, exclusively replied to Yicai that some people took their words out of context and “expanded” their words.

Zhong Nanshan told Yicai: “I said a few days ago in the Guangdong-Hong Kong-Macao Greater Bay Area cooperation agreement (forum) that compound Radix isatidis, not Radix Isatidis, has anti-coronavirus effects in the laboratory, which is effective in vitro. There is still a long way to go. As an ‘expert’, Baiyun Shan Pharmaceutical Factory should know very well, but (among them) some people took my words out of context and expanded my sentence, even saying that it is Banlangen, which is a distortion, and the relevant departments have come out to clarify.”

On October 13, a seminar on the transformation of Baiyunshan Banlangen to Macau and a cooperation signing ceremony was held in Guangzhou. Since then, a video titled “Zhong Nanshan: Baiyunshan Compound Banlangen is effective against the new coronavirus and will not talk nonsense” went viral on the Internet, causing a big stir. The outside world once questioned the authenticity of the video, and the effectiveness of Banlangen Granules was suspected to be exaggerated.

According to Guangzhou Pharmaceutical Group, the parent company of Baiyunshan, Guangzhou Baiyunshan Hutchison Whampoa Traditional Chinese Medicine Co., Ltd., Guangzhou Pharmaceutical Group (Macau) International Development Industry Co., Ltd., Guangzhou Institute of Respiratory Health and Macau University of Science and Technology officially signed the “Baiyun Mountain”. “Memorandum on the Transformation of Banlangen Research Results in Macao”, announcing that the scientific research results of Baiyunshan Banlangen and Compound Banlangen will be industrialized in Macau, which is the first landing project after the establishment of the Macau International Headquarters of GPHL.

Influenced by Zhong Nanshan’s “calling”, Baiyunshan’s Banlangen products quickly became popular. Since then, Yicai has found in some online stores that the sales of Banlangen-related products in many stores are hot, and some of them show “restocking”, and Baiyunshan’s Banlangen granules sell tens of thousands of pieces per month, showing the status of “sold out”.

And some media found that the compound Banlangen in the Jingdong Pharmacy, Ali Pharmacy, and the official flagship store of Guangyao Baiyunshan have been sold out. Among them, the “Baiyunshan Compound Banlangen Granules (10g*20 bags)” self-operated by JD.com is being purchased in Beijing.

Since then, the share price of Baiyun Mountain has also fluctuated. On October 16, Baiyunshan’s share price rose by a strong daily limit, and the value of A shares and H shares soared by about 10 billion yuan. Afterwards, Baiyunshan announced to clarify that the relevant conclusions involved in the relevant media reports are only the results of the anti-new coronavirus in vitro screening of the company’s joint venture Baiyunshan and Huang Company Compound Banlangen Granules. There are still certain uncertainties in the related work.

The stock price of Baiyun Mountain has fluctuated greatly recently, and some media questioned that its price fluctuation involves stock price manipulation. On October 23, Gao Li, a spokesperson for the China Securities Regulatory Commission, responded at the regular press conference of the China Securities Regulatory Commission, saying that the China Securities Regulatory Commission and the Exchange have paid attention to the recent media reports on Baiyun Mountain, and the company also issued a clarification announcement on the 19th. risk warning.

Gao Li said that the China Securities Regulatory Commission will pay close attention to relevant companies and related matters, and if they find violations of laws and regulations, they will be seriously investigated and dealt with in accordance with the law.

Leave a Comment

Your email address will not be published. Required fields are marked *